Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

Author： Ripamonti Carla  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.15, Iss.10, 2007-10, pp. : 1177-1184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 226-230

Spandidos Publications

Access to resources Recommend Favorite

Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases

By Song Zhengbo   Zhang Yiping  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-4

Humana Press, Inc

Access to resources Recommend Favorite

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

By Ortega C.   Faggiuolo R.   Vormola R.   Montemurro F.   Nanni D.   Goia F.   Aglietta M.  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 216-217

Informa Healthcare

Access to resources Recommend Favorite